Dr. Eric S. Ahn, MD
Ophthalmology (Ophthalmic Plastic and Reconstructive Surgery Physician)
420 E 3rd St Ste 603
Los Angeles, CA 90013
Who else practices at this address →
Los Angeles County includes primary care (7% of residents) and mental health (13% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- Albany Medical College of Union University (2008)
- Years since graduation
- 18
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 111
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2008Medical school: Albany Medical College of Union University
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Ophthalmic Plastic and Reconstructive Surgery Physician primary
CA license 151227 -
Ophthalmology Physician
MD license D0074509 · VA license 0101258022
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- East-West Eye Institute A Medical Corporation (16 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 111
- Services billed
- 945
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 78 | 68 |
| Established patient office or other outpatient visit, 20-29 minutes | 58 | 47 |
| Photography of content of eyes | 29 | 27 |
| Imaging of optic nerve | 23 | 21 |
| New patient office or other outpatient visit, 45-59 minutes | 21 | 21 |
| Exam of visual field with extended testing | 21 | 20 |
| Imaging of retina | 17 | 17 |
| Photography of the retina | 17 | 17 |
| Probing of nasal tear duct | 14 | 11 |
| Established patient complete exam of visual system | 14 | 14 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Erythromycin (erythromycin base) Other prescribers in Los Angeles, CA | 34 |
| Methylprednisolone Other prescribers in Los Angeles, CA | 28 |
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in Los Angeles, CA | 19 |
| Restasis (cyclosporine) Other prescribers in Los Angeles, CA | 11 |
| Neomycin-Polymyxin-Dexameth (neomycin/polymyxin b/dexametha) Other prescribers in Los Angeles, CA | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 2 companies reported 3 payments worth $86.99 in total to this clinician.
| AbbVie Inc. | $57.56 |
|---|---|
| Tarsus Pharmaceuticals, Inc. | $29.43 |
| Food and Beverage | $86.99 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $61,785 in research payments for these studies, mostly to the institutions running them.
- A 4-Week, Phase II, Multicenter, Randomized, Double-Masked, Vehicle- Controlled, Parallel Group Study With 4 Weeks of Follow-Up to Evaluate Safety and Efficacy of a new formulation of Recombinant Human Nerve Growth Fa…
Dompe Farmaceutici S.p.a.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.